DBS

Crown Digital Spearheads the Future of AI in F&B with Ella the Robobarista at AIM Global

Retrieved on: 
목요일, 4월 18, 2024

On being part of AIM Global, Keith Tan, CEO and Founder of Crown Digital shared "This partnership affirms Crown Digital's belief in responsible adoption of AI technologies for industrial development globally.

Key Points: 
  • On being part of AIM Global, Keith Tan, CEO and Founder of Crown Digital shared "This partnership affirms Crown Digital's belief in responsible adoption of AI technologies for industrial development globally.
  • We are proud of Ella's recognition as a positive use case in driving the autonomous future of F&B, especially with the recent resurgence of AI and Robotics.
  • Aligned with the UN Secretary-General's Our Common Agenda, AIM Global shapes a digital future that is open, secure, and beneficial to all.
  • As a new member, Crown Digital is excited to contribute to AIM Global's mission of unlocking the full potential of AI for industry.

Atlan’s Control Plane to Power Data & AI Governance Attracts $105M, Elevating Valuation to $750M

Retrieved on: 
수요일, 5월 8, 2024

“Atlan is addressing this by building the control plane for the data and AI stack, integrating trust and context into the digital fabric.”

Key Points: 
  • “Atlan is addressing this by building the control plane for the data and AI stack, integrating trust and context into the digital fabric.”
    In today's AI-forward, data-driven landscape, robust data governance is crucial.
  • At the same time, data privacy, data lineage, and data quality are key obstacles hindering generative AI implementations, according to studies from IBM and AWS .
  • Atlan addresses this challenge with its next-generation platform for data and AI governance.
  • “It’s increasingly viewed as the essential data control plane for major business initiatives like AI readiness and data democratization.

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

Retrieved on: 
수요일, 4월 24, 2024

SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release for its SmartFrame OR™ Stereotactic System.

Key Points: 
  • SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release for its SmartFrame OR™ Stereotactic System.
  • “We estimate that more than 95% of all stereotactic neuro-navigation procedures take place in the OR, supporting DBS, Laser Ablation, Biopsy, sEEG, and more.
  • The ClearPointer is intended to be used in conjunction with the SmartFrame OR and a compatible stereotactic optical navigation system for patient registration and navigation.
  • The Company has initiated limited market release, with a planned full market release in the second half of 2024.

Nium and Kapronasia Partner to Shed Light on Cross-border B2B Payment Challenges in Asia

Retrieved on: 
토요일, 4월 20, 2024

SINGAPORE, April 19, 2024 /PRNewswire/ -- Nium, the global leader in real-time, cross-border payments, and Asia's leading payments, banking, and capital markets research firm, Kapronasia, today launched "Breaking Borders: The Revolution of Real-Time Cross-Border B2B Payments in Asia" - a new data-backed white paper that addresses cross-border B2B payment challenges, current initiatives, and the important role of intermediaries.

Key Points: 
  • In global commerce, cross-border B2B payments are crucial, yet hindered by complexity, high costs, and slow processing times.
  • The research calls out initiatives, such as SWIFT GPI, Project Nexus, and ASEAN's Regional Payment Connectivity, alongside emerging technologies, that signal a brighter future for cross-border transactions.
  • "Cross-border B2B payments are critical, but they face formidable challenges - from outdated systems to regulatory complexities," said Zennon Kapron, Founder and Director of Kapronasia.
  • Intermediaries like Nium play a pivotal role in this journey, bridging gaps and reshaping the landscape of global commerce.

Nium and Kapronasia Partner to Shed Light on Cross-border B2B Payment Challenges in Asia

Retrieved on: 
토요일, 4월 20, 2024

SINGAPORE , April 19, 2024 /PRNewswire/ -- Nium, the global leader in real-time, cross-border payments, and Asia's leading payments, banking, and capital markets research firm, Kapronasia, today launched "Breaking Borders: The Revolution of Real-Time Cross-Border B2B Payments in Asia" - a new data-backed white paper that addresses cross-border B2B payment challenges, current initiatives, and the important role of intermediaries.

Key Points: 
  • In global commerce, cross-border B2B payments are crucial, yet hindered by complexity, high costs, and slow processing times.
  • The research calls out initiatives, such as SWIFT GPI, Project Nexus, and ASEAN's Regional Payment Connectivity, alongside emerging technologies, that signal a brighter future for cross-border transactions.
  • "Cross-border B2B payments are critical, but they face formidable challenges - from outdated systems to regulatory complexities," said Zennon Kapron, Founder and Director of Kapronasia.
  • Intermediaries like Nium play a pivotal role in this journey, bridging gaps and reshaping the landscape of global commerce.

Precision Neuroscience Expands Clinical Research In Brain–Computer Interface

Retrieved on: 
금요일, 3월 22, 2024

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).

Key Points: 
  • NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).
  • Its design allows for safe implantation and removal by neurosurgeons without causing harm to delicate brain tissue.
  • Dr. Ben Rapoport, Chief Science Officer and co-founder of Precision Neuroscience, underscored the significance of these studies in advancing both medical science and patient care.
  • This partnership aims to explore the diverse applications of high-resolution cortical surface arrays in clinical settings, ranging from intraoperative monitoring to neurocritical care.

Pliops Unlocks Limitless Potential of AI at NVIDIA GTC 2024

Retrieved on: 
월요일, 3월 18, 2024

Pliops , a leading provider of data processors for cloud and enterprise data centers, will be on hand at NVIDIA GTC this week to tackle these challenges head on.

Key Points: 
  • Pliops , a leading provider of data processors for cloud and enterprise data centers, will be on hand at NVIDIA GTC this week to tackle these challenges head on.
  • Pliops XDP-AccelKV universal data acceleration engine significantly minimizes the scalability challenges of AI/Gen AI applications.
  • The memory capacity and bandwidth limitations of GPUs to load AI/Gen AI models prevent them from fully utilizing their computational power.
  • It extends HBM memory with fast storage to enable terabytes-scale AI applications to run on a single GPU.

Sebia Receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devices

Retrieved on: 
금요일, 4월 5, 2024

Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices.

Key Points: 
  • Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices.
  • This qualitative analysis is performed by capillary electrophoresis with the CAPILLARYS 3 DBS automated instrument.
  • This offer provides laboratories a gain in operational efficiency with high throughput and a full traceability from DBS card up to the result through a cyber-secured environment.
  • This will help laboratories to make timely and accurate decisions for newborns” said Arnaud Collin, Sebia Group Vice President Global Regulatory Affairs & Quality.

Swift Sets Industry Up for Seamless Introduction of CBDCs for Cross-Border Transactions as Interlinking Solution Finds More Use Cases

Retrieved on: 
월요일, 3월 25, 2024

Swift’s solution has already been shown to enable cross-border transfers and connect CBDCs on different networks with each other, as well as with fiat currencies.

Key Points: 
  • Swift’s solution has already been shown to enable cross-border transfers and connect CBDCs on different networks with each other, as well as with fiat currencies.
  • The second phase of sandbox testing went further, exploring more complex use cases, using Swift’s solution to connect and orchestrate transactions across simulated digital trade and tokenised asset and FX networks, alongside CBDCs for payments.
  • Swift now plans to extend its solution to support a wider range of emerging digital networks in addition to CBDCs, such as platforms for tokenised deposits.
  • This will help to facilitate access and usage of CBDCs in the new complex world of digital payments.

Unitech Launches New Rugged Smartphone: Boosting Retail with Free OS Upgrades, Extended Battery Life, and Advanced 5G Connectivity

Retrieved on: 
목요일, 3월 14, 2024

It also includes a battery info & battery care APP for charging settings, designed to extend the battery's life cycle.

Key Points: 
  • It also includes a battery info & battery care APP for charging settings, designed to extend the battery's life cycle.
  • Complimentary OS Upgrades: Unitech Shield service ensures free regular OS updates, enhancing device security and performance.
  • Extended Battery Life: A powerful 5000mAh battery ensures uninterrupted operation throughout the day, ideal for continuous mobile device usage.
  • DBS technology supports simultaneous dual-band transmissions (2.4 & 5GHz), ensuring faster, more reliable network performance, vital for real-time retail operations.